Delivery Order SPE2DB20D1100-SPE2DB23FD8K1
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of epinephrine 0.3 mg auto-injectors. The contract has a ceiling value of $1,495.30 and a period of performance through April 1, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.3 mg auto-injectors. The single-award, firm-fixed-price delivery order, valued at $5,644.60, has a completion date of March 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of epinephrine 0.3 mg auto-injectors. The $1,765.56 delivery order is priced on a firm-fixed-price basis and has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, with a ceiling value of $11,102.21 and a performance period through March 28, 2024. This is a firm fixed price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,854.68, is a delivery order for epinephrine 0.3 mg auto-injectors. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,389,079 epinephrine 0.3 mg auto-injectors. The $1,315.28 fixed-price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen is a subsidiary of the larger Cencora, Inc. parent company. This award is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $1,186.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.3 mg Epinephrine auto-injectors, with a completion date of March 31, 2023. The contract is structured as a firm fixed-price delivery order and is not set aside for any specific business type, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The Delivery Order contract, valued at $1,814.54, has a firm fixed-price pricing type and an ultimate completion date of July 10, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Epinephrine 0.3 mg auto-injectors. The contract, valued at $4,909.18, is a firm fixed-price delivery order with a completion date of March 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Epinephrine 0.3 mg auto-injectors. The $1,228.55 fixed-price contract was awarded on December 13, 2021, with a completion date of December 14, 2021. This contract was awarded through full and open competition, without any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD8K1Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.3 mg auto-injectors. The contract is a Firm Fixed Price Delivery Order valued at $26,363.37, with a completion date of September 27, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, running through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.4k | 9/26/23 |